Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Return on Capital %

Arbutus Biopharma Cp Return on Capital % Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Return on Capital % from 2010 to 2018.
  • Arbutus Biopharma Cp Return on Capital % for the quarter ending December 12, 2018 was -19.07 a -3.10% increase of 0.59 year over year
  • Arbutus Biopharma Cp Return on Capital % for the last 12 months ending December 12, 2018 was -22.23 a 16.20% decrease of -3.60 year over year
  • Arbutus Biopharma Cp Annual Return on Capital % for 2018 was -22.23 a 9.25% decrease of -2.06 from 2017
  • Arbutus Biopharma Cp Annual Return on Capital % for 2017 was -20.18 a 44.53% decrease of -8.98 from 2016
  • Arbutus Biopharma Cp Annual Return on Capital % for 2016 was -11.19 a 10.31% decrease of -1.15 from 2015
Other Margins & Efficiency Metrics:
  • Arbutus Biopharma Cp EBITDA Margin for the quarter ending September 09, 2017 was $-142m a -71.85% increase of 102m year over year
  • Arbutus Biopharma Cp Return on Equity % for the quarter ending December 12, 2018 was -35.22 a 4.57% decrease of -1.61 year over year
View Chart On Koyfin

Quarterly ABUS Return on Capital % Data

12/2018-19.07
09/2018-19.97
06/2018-20.72
03/2018-19.66
12/2017-32.03
09/2017-17.56
06/2017-25.05
03/2017-21.99
12/2016-15.37
09/2016-9.42

Annual ABUS Return on Capital % Data

2018-22.23
2017-20.18
2016-11.19
2015-10.04
2014-27.99
2013-15.17
2012-35.06
2011-84.68
2010-24.85
2009-15.34